# Mindfulness and Psychedelics

> **NCT05780216** · EARLY_PHASE1 · COMPLETED · sponsor: **Milan Scheidegger** · enrollment: 40 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** DMT + harmine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05780216
- **Lead sponsor:** Milan Scheidegger
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-20
- **Primary completion:** 2023-08-05
- **Final completion:** 2023-09-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05780216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05780216, "Mindfulness and Psychedelics". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05780216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*